Serotonin Agonists
Research News and Information

Saturday, November 21, 2009

Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation.

30 Oct 2009 OBJECT: Cerebral ischemia remains the key cause of disability and death in the late phase after subarachnoid hemorrhage (SAH), and its pathogenesis is still poorly understood. The purpose of this study was to examine whether the change in ... Read more...

Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.

30 Oct 2009 The ability of tonabersat to relieve the symptoms of migraine attacks with or without aura was evaluated in a randomized, double-blind, placebo-controlled, multicentre, parallel-group study. Patients received 20 or 40 mg of tonabersat, or 50 mg of ... Read more...

Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.

29 Sep 2009 Substantial evidence suggests that pharmacological manipulations of neural serotonin pathways influence ingestive behaviors. Despite the known role of the nucleus accumbens in directing appetitive and consummatory behavior, there has been little ... Read more...

Latest indexed articles for 'Serotonin Agonists'

These are the very latest articles for this heading:

• Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation. 30 Oct 2009
• Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. 30 Oct 2009
• Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion. 29 Sep 2009
• Rizatriptan induced acute on top of chronic ischemic colitis. 29 Sep 2009
• In vivo interactions between BZP and TFMPP (party pill drugs). 23 Sep 2009
• Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia. 21 Sep 2009
• Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. 18 Sep 2009
• The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances. 10 Sep 2009
• Serotonin targets inhibitory synapses to induce modulation of network functions. 10 Sep 2009
• EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. 30 Aug 2009
• Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats. 30 Aug 2009
• Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device. 30 Aug 2009
• Alteration of synaptic transmission in the hippocampal-mPFC pathway during extinction trials of context-dependent fear memory in juvenile rat stress models. 30 Aug 2009
• Serotonergic-postsynaptic receptors modulate gripping-induced immobility episodes in male taiep rats. 30 Aug 2009
• In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. 20 Aug 2009
• A pilot study of rizatriptan and visually-induced motion sickness in migraineurs. 4 Aug 2009
• 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. 3 Aug 2009
• The bovine mammary gland expresses multiple functional isoforms of serotonin receptors. 2 Aug 2009
• Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study. 30 Jul 2009
• Assessment of gastric motor function by cine magnetic resonance imaging. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Serotonin Agonists'

Definition: Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of MIGRAINE DISORDERS.

Registry Number: 0

Descriptor UI: D017366

Alternative terms: Serotonin Agonists; Agonists, Serotonin; 5-HT Agonists; 5 HT Agonists; Agonists, 5-HT; 5-Hydroxytryptamine Agonists; 5 Hydroxytryptamine Agonists; Agonists, 5-Hydroxytryptamine; 5-Hydroxytrytamine Agonist; 5 Hydroxytrytamine Agonist; Agonist, 5-Hydroxytrytamine; Receptor Agonists, Serotonin; Agonists, Serotonin Receptor; Serotonergic Agonists; Agonists, Serotonergic; Serotonin Agonist; Agonist, Serotonin; Serotonin Receptor Agonist; Agonist, Serotonin Receptor; Receptor Agonist, Serotonin; Serotonin Receptor Agonists; 5-HT Agonist; 5 HT Agonist; Agonist, 5-HT; Serotonergic Agonist; Agonist, Serotonergic; 5-HT3 Agonists; 5 HT3 Agonists; Agonists, 5-HT3; 5-HT3 Agonist; 5 HT3 Agonist; Agonist, 5-HT3; 5-HT1 Agonists; 5 HT1 Agonists; Agonists, 5-HT1; 5-HT1 Agonist; 5 HT1 Agonist; Agonist, 5-HT1; 5-HT2 Agonists; 5 HT2 Agonists; Agonists, 5-HT2; 5-HT2 Agonist; 5 HT2 Agonist; Agonist, 5-HT2;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.850.800; D27.505.696.577.850.800;

History Note: 93

Technical Notes: do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN AGON or SEROTONIN AG